World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
107
Citations
56296
World Ranking
540
National Ranking
325

Medicine

D-Index
108
Citations
57265
World Ranking
5906
National Ranking
3166

Douglas T. Fearon publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Douglas T. Fearon sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 313 publications — 66th percentile

66% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Douglas T. Fearon D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Douglas T. Fearon sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 107 D-Index — 89th percentile

89% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2001 - Member of the National Academy of Sciences
  • 1999 - Fellow of the Royal Society, United Kingdom
  • 1999 - Fellow of the American Academy of Arts and Sciences
  • 1990 - Fellow of the American Association for the Advancement of Science (AAAS)
  • Fellow of The Academy of Medical Sciences, United Kingdom
  • Member of the Association of American Physicians
  • Member of the European Molecular Biology Organization (EMBO)
  • Fellow of The Academy of Medical Sciences, United Kingdom
  • Member of the Association of American Physicians
  • Member of the European Molecular Biology Organization (EMBO)
  • Fellow of The Academy of Medical Sciences, United Kingdom
  • Member of the Association of American Physicians
  • Member of the European Molecular Biology Organization (EMBO)
  • Fellow of The Academy of Medical Sciences, United Kingdom
  • Member of the Association of American Physicians
  • Member of the European Molecular Biology Organization (EMBO)

Overview

Douglas T. Fearon is affiliated with Cold Spring Harbor Laboratory in the United States. Their research focuses on multiple areas within medicine, immunology and microbiology, and biochemistry, genetics and molecular biology, with particular emphasis on immunology, oncology, molecular biology, cell biology, and epidemiology.

The scientist's work covers several major topics including immunotherapy and immune responses, CAR-T cell therapy research, immune cell function and interaction, cancer immunotherapy and biomarkers, single-cell and spatial transcriptomics, T-cell and B-cell immunology, and pancreatic and hepatic oncology research.

Douglas T. Fearon has published extensively in a range of venues. Frequent publication venues include bioRxiv (Cold Spring Harbor Laboratory), Proceedings of the National Academy of Sciences, Nature, The Journal of Immunology, and Nature Reviews Cancer.

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Proceedings of the National Academy of Sciences
  • Nature
  • The Journal of Immunology
  • Nature reviews. Cancer

Notable recent publications include:

  • A framework for advancing our understanding of cancer-associated fibroblasts, 2020, Nature Reviews Cancer
  • Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I, 2020, Nature
  • CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune response, 2020, Proceedings of the National Academy of Sciences
  • Carcinomas assemble a filamentous CXCL12-keratin-19 coating that suppresses T cell-mediated immune attack, 2022, Apollo (University of Cambridge)
  • Cancer cell CCR2 orchestrates suppression of the adaptive immune response, 2020, The Journal of Experimental Medicine

They collaborate frequently with several coauthors, including Philip Moresco (9 publications), Tobias Janowitz (6 publications), Zhikai Wang (6 publications), David A. Tuveson (5 publications), and Ran Yan (5 publications).

Douglas T. Fearon has received multiple recognitions, including:

  • Member of the National Academy of Sciences, 2001
  • Fellow of the Royal Society, United Kingdom, 1999
  • Fellow of the American Academy of Arts and Sciences, 1999
  • Fellow of the American Association for the Advancement of Science (AAAS), 1990
  • Member of the Association of American Physicians
  • Member of the European Molecular Biology Organization (EMBO)
  • Fellow of The Academy of Medical Sciences, United Kingdom

Best Publications

  • A framework for advancing our understanding of cancer-associated fibroblasts

    Erik Sahai;Igor Astsaturov;Edna Cukierman;David G. DeNardo

  • The instructive role of innate immunity in the acquired immune response.

    Douglas T. Fearon;Richard M. Locksley

  • T cell exclusion, immune privilege, and the tumor microenvironment

    Johanna A. Joyce;Douglas T. Fearon;Douglas T. Fearon

  • Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer

    Daniel Öhlund;Daniel Öhlund;Daniel Öhlund;Abram Handly-Santana;Abram Handly-Santana;Giulia Biffi;Giulia Biffi;Ela Elyada;Ela Elyada

  • Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer.

    Christine Feig;James O. Jones;Matthew Kraman;Richard J. B. Wells

  • C3d of Complement as a Molecular Adjuvant: Bridging Innate and Acquired Immunity

    Paul W. Dempsey;Michael E. D. Allison;Srinivas Akkaraju;Christopher C. Goodnow

  • Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice.

    Jean Albrengues;Mario Anthonio Shields;David Ng;Chun Gwon Park

  • Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2.

    J D Fingeroth;J J Weis;T F Tedder;J L Strominger

  • Suppression of Antitumor Immunity by Stromal Cells Expressing Fibroblast Activation Protein–α

    Matthew Kraman;Paul J. Bambrough;James N. Arnold;Edward W. Roberts

  • Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis

    Harlan F. Weisman;Thomas Bartow;Michelle K. Leppo;Henry C. Marsh

  • Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer.

    Vinod P. Balachandran;Marta Łuksza;Julia N. Zhao;Vladimir Makarov

  • Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I

    Keisuke Yamamoto;Anthony Venida;Julian Yano;Douglas E. Biancur

  • Distinct fibroblast subsets drive inflammation and damage in arthritis.

    Adam P. Croft;Joana Campos;Kathrin Jansen;Jason D. Turner

  • Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyte.

    DT Fearon

  • CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes

    Robert H. Carter;Douglas T. Fearon

  • Control of the amplification convertase of complement by the plasma protein beta1H.

    J M Weiler;M R Daha;K F Austen;D T Fearon

  • Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system.

    A Nicholson-Weller;J Burge;D T Fearon;P F Weller

  • Epstein-Barr Virus gp350/220 Binding to the B Lymphocyte C3d Receptor Mediates Adsorption, Capping, and Endocytosis

    Jerome Tanner;Janis Weis;Janis Weis;Douglas Fearon;Douglas Fearon;Young Whang

  • A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP

    G. M. Doody;L. B. Justement;C. C. Delibrias;R. J. Matthews

  • Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex.

    Douglas T. Fearon;Michael C. Carroll

  • Structure and Function of the Complement Receptors, CR1 (CD35) and CR2 (CD21)

    Joseph M. Ahearn;Douglas T. Fearon

Frequent Co-Authors

K. Frank Austen
K. Frank Austen Brigham and Women's Hospital
David A. Tuveson
David A. Tuveson Cold Spring Harbor Laboratory
Janis J. Weis
Janis J. Weis University of Utah
Christopher D. Buckley
Christopher D. Buckley University of Oxford
Andrew Filer
Andrew Filer University of Birmingham
Thomas F. Tedder
Thomas F. Tedder Duke University
Mohamed R. Daha
Mohamed R. Daha Leiden University
John A. Smith
John A. Smith University of Alabama at Birmingham
Mikala Egeblad
Mikala Egeblad Cold Spring Harbor Laboratory
Francis D. Moore
Francis D. Moore Brigham and Women's Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related online degrees can open up diverse career pathways in healthcare and research. Many professionals in this field often pursue advanced nursing roles, such as Psychiatric-Mental Health Nurse Practitioners, where understanding immune responses is crucial. If cost is a concern, the cheapest pmhnp certificate programs offer affordable options to advance specialized expertise.

Many Immunology graduates transition into Nurse Practitioner roles, often looking to enhance their skills through bridge programs. For instance, those moving from Family Nurse Practitioner roles can benefit from an fnp to acute care np bridge program to gain critical care experience, which complements immunological knowledge in acute patient settings.

Salary potential is an important factor when selecting a career path. According to data on the highest paid dnp specialties, specialties closely aligned with Immunology-related fields often see competitive compensation, reflecting the demand for expert care and research capabilities.

For accelerated advancement, considering one of the accelerated nurse practitioner programs can fast-track your education and career. These programs are designed for motivated students and professionals seeking to enter or advance quickly within healthcare roles linked to Immunology.

Best Scientists Citing Douglas T. Fearon

Trending Scientists

Recently Published Articles